Gilead Sciences, Inc. (GILD) Annual Report Sheds Light on Revenue and Profit
In 2023, Gilead's total revenues decreased by 1% due to lower Veklury sales, offset by higher HIV and Oncology sales. Net income rose to $5.7 billion, with diluted earnings per...









